In a new podcast Professor J Michael Gaziano shares his viewpoint, gained from decades of research and clinical practice, on aspirin’s role as a primary CVD prevention strategy. The podcast explores the need for primary CVD prevention and looks at the benefits and risk of using aspirin as a preventative strategy in this context. Mike explains the difficulties of applying population-based data gained from clinical research to individuals in the clinic. Professor Gaziano also explains the importance of being able to use information to empower and involve patients in decision making about their care and management. He explores how this involvement can help improve concordance with aspirin primary prevention therapy.
Have something to say about aspirin?
Please fill in the form below and we will contact you with further information.